The skin is a dynamic immune organ where resident structural, stromal, and immune cells interact continuously to maintain tissue integrity and defend against environmental challenges. This balance enables effective responses to injury, infection, and stress while preventing excessive inflammation, autoimmunity, or tissue damage. Disruption of homeostasis can drive a wide spectrum of conditions, including chronic inflammation, autoimmune disorders, infections, and cancer. Understanding the cellular and molecular interactions that regulate these responses is essential for uncovering mechanisms that preserve skin health and for identifying therapeutic opportunities.
This Research Topic aims to gather studies exploring how local immune networks are established, maintained, and dysregulated in the skin. We welcome contributions examining the interplay between immune and non-immune resident cells, the regulation of inflammatory responses, and the pathways that govern immune homeostasis. By integrating basic, translational, and clinical research, the collection seeks to highlight mechanisms driving both health and disease and their relevance for therapy development.
Topics of interest include, but are not limited to: - Cellular and molecular mechanisms underlying cutaneous immune regulation - Dysregulation of skin immunity in inflammatory, autoimmune, infectious, and neoplastic conditions - Crosstalk between structural, stromal, and immune cells - Translational insights or therapeutic strategies targeting skin immune pathways.
We invite the following article types: Original Research, Review, Mini Review, Case Report, and Brief Research Report that combine mechanistic insight with clinical relevance.
By showcasing innovative findings and approaches, this collection will advance understanding of skin immunology and support the development of strategies to restore immune balance and promote skin health.
Please note that Dr. Maria-Angeliki Gkini has been an investigator and/or has received fees/honoraria as an advisory board member and/or speaker and/or has received education support and/or travel grants from NIHR studies, AbbVie, Novartis, Johnson & Johnson, Almirall, LEO Pharma, UCB, Pharmaserve-Lilly, Sanofi, Pfizer, Faran, AMGEN, Argenx, MSD, Bristol Myers Squibb, Soterius Pharma, Sanofi,Oruka Therapeutics, Frezyderm, Pierre Fabre, Galderma, L’Oreal, Beiersdorf and Hair + Me. She is an employee of Dr Haus Dermatology. She has received grants from the EADV and the British Skin Foundation. She is also an executive committee member of ESDAP, a member of EADV Statutes and Development Committee, and she is a member of Alopecia UK Research Committee, Member of the International Psoriasis Council Membership Committee , Junior Councilor at International Psoriasis Council, IPC Early Career Program Steering Committee Chair, Member of the Womens’ Dermatology Society Awards Committee, and Member of the Dermatology–Rheumatology Collaboration Y-GRAPPA Committee.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Case Report
Classification
Clinical Trial
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Methods
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.